Recently, Yuanvore Medicine Pathogenic Microbiology Laboratory successfully passed the BSL-2 registration certification, that is, P2 laboratory certification. This is another achievement of the company's laboratory construction, which will provide a stronger guarantee for life science research and biomedical research and development.

Biosafety level laboratory (BSL-2), also known as P2 laboratory, is a classification of laboratory biosafety levels, indicating that the pathogens and biological factors involved in the experiments carried out in this laboratory are at level II. It mainly serves pharmaceutical research and development, animal experiments, diagnostic research, etc., suitable for the study of human body, animals and plants or the environment with moderate or potentially dangerous pathogenic factors, which will not cause serious harm to healthy adults, animals and the environment, with effective prevention and treatment measures.

The secondary Biosafety laboratory of Yuanwu Medical is mainly used for cell reprogramming, gene editing, cell engineering transformation, drug quality control testing and other experiments. The successful approval of the BSL-2 laboratory indicates that the company has the hardware conditions and technical capabilities to carry out microbial culture and testing, cell infection and pathogenic microorganism detection, which will help the company's iPSC(induced pluripotent stem cell) drug development and application.

Yuanvore Medicine P2 Laboratory

About Yuanvore Medicine

Shanghai Yuanvore Medicine Technology Co., Ltd. is a regenerative medicine company focusing on the development and application of iPSC(induced pluripotent stem cell) technology. iPSC provides unlimited possibilities for regenerative medicine with its unique ability of infinite proliferation and development totipotency. Together with the world's leading iPSC expert team, we are committed to creating the "Yuanwuprogram" - to achieve a global breakthrough in the industrialization of iPSC induction, differentiation and amplification, and carry out innovative research and development around clinical high incidence diseases such as nervous system, immune system and metabolic system, and build an efficient, stable and accurate iPSC technology platform to treat chronic human diseases. Create a path of regeneration for human life and health.

We believe that better cell therapy comes from better cells. Yuanyuan Medical will build a "super cell bank" with strict quality control and innovative transformation technology to ensure that the quantity, quality, purity and repeatability of IPscs meet the requirements of academic research, drug discovery and cell therapy development.

We combine stem cell biology with genomic approaches to investigate restorative treatments for patients. With the clinical unmet need for severe chronic disease as the core product development, to provide reliable quality, affordable iPSC treatment products for patients around the world.